Novartis (Portfolio of Ophthalmic Antibiotics) is Buildings and Property in Switzerland that focus on Oftalmolosa Cusi Gentamicina business. They cover business area such as portfolio, five ocular antibiotic product, Colircusi Gentadexa, Colircusi Gentamicin, Oftalmolosa Cusi Gentamicina, Oftalmolosa Cusi Erythromycin, macrolide, Oftalmolosa Cusi Aureomycin, tetracycline, Oftacilox, fluoroquinolone.
-
Oftalmolosa Cusi Gentamicina
-
4002 Basel
Switzerland
Private
portfoliofive ocular antibiotic productColircusi GentadexaColircusi GentamicinOftalmolosa Cusi GentamicinaOftalmolosa Cusi ErythromycinmacrolideOftalmolosa Cusi AureomycintetracyclineOftaciloxfluoroquinolone
* We use standard office opening hours in near Novartis (Portfolio of Ophthalmic Antibiotics)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Novartis (Portfolio Of Ophthalmic Antibiotics) is Buildings and Property business from Switzerland that founded in - ( years old in ), Novartis (Portfolio of Ophthalmic Antibiotics) business is focusing on Oftalmolosa Cusi Gentamicina.
Novartis (Portfolio of Ophthalmic Antibiotics) headquarter office and corporate office address is located in 4002 Basel Switzerland.
Novartis (Portfolio of Ophthalmic Antibiotics) was founded in Switzerland.
In , Novartis (Portfolio of Ophthalmic Antibiotics) is currently focus on Oftalmolosa Cusi Gentamicina sector.
Above is snippet of Google Trends for "Oftalmolosa Cusi Gentamicina" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Novartis (Portfolio of Ophthalmic Antibiotics), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
